Trials / Completed
CompletedNCT01624116
Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
A Comparison of Four Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetic Patients and the Effect of Add-On Acarbose on Glycaemic Excursions During Ramadan Fasting
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 161 (actual)
- Sponsor
- Services Hospital, Lahore · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Type 2 diabetic patients who fast during Ramadan experience swings in glycaemic control between hypoglycaemic troughs and hyperglycaemic spikes. Hence, the dual challenge in fasting diabetics is to identify which treatment modality leads to the most stable blood glucose levels during a fast and how to smooth out these excursions and reduce risks of fast to a minimum.
Detailed description
Study Objectives: * To compare changes in clinical and metabolic parameters from baseline to the end of four weeks fasting in Ramadan between four treatment arms: * diet and lifestyle measures alone. * metformin monotherapy. * combination therapy with metformin + sulfonylurea. * combination therapy with metformin + sitagliptin. * To compare the 24 hour CGMS profile during Ramadan fasting in type 2 diabetic patients before and after addition of acarbose to these pre-existing sub-maximal hypoglycaemic regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acarbose | Tab.Acarbose 50mg BD for one day in addition to existing medication to 10% of patients in each treatment arm. |
| OTHER | Diet and lifestyle | Patients would follow a 1200 KCal Ramadan diet plan, and exercise for 30 minutes per day |
| DRUG | Metformin | Patients on metformin monotherapy prior to Ramadan will continue on it, in the same dose |
| DRUG | Metformin/ Glimepride | Metformin 500mg and Glimepride 1mg in a combination tablet. Dosage frequency BD |
| DRUG | Metformin/Sitagliptin | Metformin 500 and sitagliptin 50mg in a combination tablet,dosage frequency BD. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2012-06-20
- Last updated
- 2012-06-20
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT01624116. Inclusion in this directory is not an endorsement.